AEVIS VICTORIA Aktie

AEVIS VICTORIA für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2PLW7 / ISIN: CH0478634105

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
12.05.2025 07:00:25

AEVIS VICTORIA SA – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025.

AEVIS VICTORIA SA / Key word(s): Quarter Results
AEVIS VICTORIA SA – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025.

12-May-2025 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

Fribourg, 12 May 2025

AEVIS VICTORIA SA (AEVS.SW) – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025.

AEVIS VICTORIA SA (AEVIS) recorded consolidated revenues of CHF 329.7 million in the first quarter of 2025 (Q1 2024: CHF 281.9 million), marking a 17.0% increase. AEVIS’s consolidated operating divisions, Swiss Medical Network and MRH Switzerland AG, achieved organic growth of 3.2%. The expansion of Swiss Medical Network’s scope – particularly through the integration of Spital Zofingen AG and PDS Medical SA (CentroMedico) – further supported this momentum.

Swiss Medical Network SA generated revenues of CHF 258.6 million (Q1 2024: CHF 213.0 million), an increase of 21.4%. This growth was driven by the significant expansion of the outpatient network and the integration of several new sites across the country's linguistic regions. The development of integrated care continues with the aim of rolling out the model launched in the Jura Arc region in 2024 and in Ticino in 2025 to the whole of Switzerland. A new region covered by the alternative insurance product developed by Visana, Viva Health, is set to launch on 1 January 2026.

MRH Switzerland AG (AEVIS’s hospitality division) continued to grow, achieving consolidated revenues of CHF 67.1 million (Q1 2024: CHF 64.7 million), an increase of 3.7%. This organic growth was driven by excellent performance in particular in Interlaken, Zermatt and Davos.

The Group’s other consolidated segments (Real Estate and Others) contributed only marginally to first-quarter revenue, amounting to CHF 4.1 million (Q1 2024: CHF 4.3 million). However, additional income from the disposal of various non-strategic real estate assets is expected to support revenue growth in these segments for the rest of 2025.

Operations continue to perform as expected, and the acquisitions completed in 2024 should enable the Group to maintain the growth rate achieved in the first quarter for the full year.

AEVIS will hold its first «Capital Markets Day» on Wednesday, 4 June 2025, from 11:00 to 16:00 at the Genolier Innovation Hub in Genolier. The invitation can be downloaded via this link:
Capital Markets Day.

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, prb@dynamicsgroup.ch, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren, svanderschueren@aevis.com, +41 (0) 79 635 04 10

AEVIS VICTORIA SA - Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network Holding SA (76.3%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, MRH Switzerland AG, a luxury hotel group managing eleven hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.



End of Inside Information

2134488  12-May-2025 CET/CEST

Analysen zu AEVIS VICTORIA SAmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

AEVIS VICTORIA SA 14,05 -1,75% AEVIS VICTORIA SA